Hematologic diseases encompass a wide range of disorders affecting the blood and blood-forming organs, ranging from relatively benign conditions such as anemia, to more severe cancers of the blood. Common hematologic tumors include leukemia, lymphoma and multiple myeloma, which are characterized by the abnormal proliferation of blood cells or lymphatic tissue. These conditions necessitate specialized treatment approaches, such as chemotherapy, immunotherapy (including cellular immunotherapy), and hematopoietic cell transplantation. Timely diagnosis and tailored treatment are crucial for effectively managing these intricate hematologic diseases. Early diagnosis and personalized treatment plans are crucial for managing these complex hematologic diseases effectively.

Solid tumors are abnormal masses of tissues that multiply when the cells grow and divide beyond control. They grow in organs or tissues, such as the lungs, pancreas, or gastrointestinal tract, unlike blood cancers that involve cells in the blood or bone marrow. Malignant tumors can invade other tissues and spread throughout the body, so the treatment for solid tumors needs special attention.

Patient-centered and guided by clinical needs, the GoBroad team has created a patient-driven Multidisciplinary Care (MDC) model for interdisciplinary and all-around discussion and research on the conditions and nursing measures for patients with difficult, complex, and critical tumors. This approach effectively integrates conventional therapies with innovative diagnostic and treatment technologies, enabling patients to receive more advanced, personalized, and scientifically cutting-edge treatments in a comfortable setting. It not only offers them greater chances of recovery but also enhances their quality of life significantly. These philosophies and practices have helped us to rank among the best oncology hospitals in the world.